ID   PTK7_HUMAN              Reviewed;        1070 AA.
AC   Q13308; A8K974; B7Z477; E9PFZ5; Q13417; Q5T650; Q6IQ54; Q8NFA5;
AC   Q8NFA6; Q8NFA7; Q8NFA8;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   10-MAY-2017, entry version 170.
DE   RecName: Full=Inactive tyrosine-protein kinase 7;
DE   AltName: Full=Colon carcinoma kinase 4;
DE            Short=CCK-4;
DE   AltName: Full=Protein-tyrosine kinase 7;
DE   AltName: Full=Pseudo tyrosine kinase receptor 7;
DE   AltName: Full=Tyrosine-protein kinase-like 7;
DE   Flags: Precursor;
GN   Name=PTK7; Synonyms=CCK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Colon carcinoma, and Placenta;
RX   PubMed=7478540;
RA   Mossie K., Jallal B., Alves F., Sures I., Plowman G.D., Ullrich A.;
RT   "Colon carcinoma kinase-4 defines a new subclass of the receptor
RT   tyrosine kinase family.";
RL   Oncogene 11:2179-2184(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fibroblast;
RX   PubMed=8882711; DOI=10.1093/oxfordjournals.jbchem.a021228;
RA   Park S.-K., Lee H.-S., Lee S.-T.;
RT   "Characterization of the human full-length PTK7 cDNA encoding a
RT   receptor protein tyrosine kinase-like molecule closely related to
RT   chick KLG.";
RL   J. Biochem. 119:235-239(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND NUCLEOTIDE SEQUENCE [MRNA]
RP   (ISOFORMS 1; 2; 3; 4 AND 5).
RC   TISSUE=Testis;
RX   PubMed=12427550; DOI=10.1016/S0167-4781(02)00536-5;
RA   Jung J.-W., Ji A.-R., Lee J., Kim U.-J., Lee S.-T.;
RT   "Organization of the human PTK7 gene encoding a receptor protein
RT   tyrosine kinase-like molecule and alternative splicing of its mRNA.";
RL   Biochim. Biophys. Acta 1579:153-163(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 6).
RC   TISSUE=Testis, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   GLYCOSYLATION AT ASN-646.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-646.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   FUNCTION.
RX   PubMed=18471990; DOI=10.1016/j.bbrc.2008.04.168;
RA   Shin W.-S., Maeng Y.-S., Jung J.-W., Min J.-K., Kwon Y.-G., Lee S.-T.;
RT   "Soluble PTK7 inhibits tube formation, migration, and invasion of
RT   endothelial cells and angiogenesis.";
RL   Biochem. Biophys. Res. Commun. 371:793-798(2008).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-116; ASN-175; ASN-268 AND
RP   ASN-283.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [12]
RP   FUNCTION.
RX   PubMed=20558616; DOI=10.1182/blood-2010-01-262352;
RA   Prebet T., Lhoumeau A.-C., Arnoulet C., Aulas A., Marchetto S.,
RA   Audebert S., Puppo F., Chabannon C., Sainty D., Santoni M.-J.,
RA   Sebbagh M., Summerour V., Huon Y., Shin W.-S., Lee S.-T., Esterni B.,
RA   Vey N., Borg J.-P.;
RT   "The cell polarity PTK7 receptor acts as a modulator of the
RT   chemotherapeutic response in acute myeloid leukemia and impairs
RT   clinical outcome.";
RL   Blood 116:2315-2323(2010).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, INDUCTION, CLEAVAGE, AND MUTAGENESIS
RP   OF LEU-622; MET-641 AND MET-701.
RX   PubMed=20837484; DOI=10.1074/jbc.M110.165159;
RA   Golubkov V.S., Chekanov A.V., Cieplak P., Aleshin A.E., Chernov A.V.,
RA   Zhu W., Radichev I.A., Zhang D., Dong P.D., Strongin A.Y.;
RT   "The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a
RT   highly efficient proteolytic target of membrane type-1 matrix
RT   metalloproteinase: implications in cancer and embryogenesis.";
RL   J. Biol. Chem. 285:35740-35749(2010).
RN   [14]
RP   FUNCTION.
RX   PubMed=21103379; DOI=10.1371/journal.pone.0014018;
RA   Meng L., Sefah K., O'Donoghue M.B., Zhu G., Shangguan D., Noorali A.,
RA   Chen Y., Zhou L., Tan W.;
RT   "Silencing of PTK7 in colon cancer cells: caspase-10-dependent
RT   apoptosis via mitochondrial pathway.";
RL   PLoS ONE 5:E14018-E14018(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   FUNCTION, INTERACTION WITH CTNNB1, AND REGION.
RX   PubMed=21132015; DOI=10.1038/embor.2010.185;
RA   Puppo F., Thome V., Lhoumeau A.-C., Cibois M., Gangar A., Lembo F.,
RA   Belotti E., Marchetto S., Lecine P., Prebet T., Sebbagh M.,
RA   Shin W.-S., Lee S.-T., Kodjabachian L., Borg J.-P.;
RT   "Protein tyrosine kinase 7 has a conserved role in Wnt/beta-catenin
RT   canonical signalling.";
RL   EMBO Rep. 12:43-49(2011).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-276; SER-410; ASP-745; GLN-766;
RP   VAL-777; ARG-783; VAL-933; THR-1029 AND GLN-1038.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Inactive tyrosine kinase involved in Wnt signaling
CC       pathway. Component of both the non-canonical (also known as the
CC       Wnt/planar cell polarity signaling) and the canonical Wnt
CC       signaling pathway. Functions in cell adhesion, cell migration,
CC       cell polarity, proliferation, actin cytoskeleton reorganization
CC       and apoptosis. Has a role in embryogenesis, epithelial tissue
CC       organization and angiogenesis. {ECO:0000269|PubMed:18471990,
CC       ECO:0000269|PubMed:20558616, ECO:0000269|PubMed:20837484,
CC       ECO:0000269|PubMed:21103379, ECO:0000269|PubMed:21132015}.
CC   -!- SUBUNIT: Interacts with CTNNB1. {ECO:0000269|PubMed:21132015}.
CC   -!- INTERACTION:
CC       P35222:CTNNB1; NbExp=5; IntAct=EBI-2803245, EBI-491549;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:20837484};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:20837484}.
CC       Cell junction {ECO:0000269|PubMed:20837484}. Note=Colocalizes with
CC       MMP14 at cell junctions. Also localizes at the leading edge of
CC       migrating cells.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=PTK7-1;
CC         IsoId=Q13308-1; Sequence=Displayed;
CC       Name=2; Synonyms=PTK7-2;
CC         IsoId=Q13308-2; Sequence=VSP_037182;
CC       Name=3; Synonyms=PTK7-3;
CC         IsoId=Q13308-3; Sequence=VSP_037181;
CC       Name=4; Synonyms=PTK7-4;
CC         IsoId=Q13308-4; Sequence=VSP_037183;
CC       Name=5; Synonyms=PTK7-5;
CC         IsoId=Q13308-5; Sequence=VSP_037184, VSP_037185;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=6;
CC         IsoId=Q13308-6; Sequence=VSP_044775;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in lung, liver, pancreas,
CC       kidney, placenta and melanocytes. Weakly expressed in thyroid
CC       gland, ovary, brain, heart and skeletal muscle. Also expressed in
CC       erythroleukemia cells. But not expressed in colon.
CC   -!- INDUCTION: Higher expression in cell lines established from normal
CC       non-tumorigenic tissues compared to cell lines established from
CC       highly metastatic invasive carcinomas (at protein level).
CC       {ECO:0000269|PubMed:20837484}.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive.
CC   -!- PTM: MMP14 cleaves PTK7 between Pro-621 and Leu-622 generating an
CC       N-terminal soluble (70 kDa) fragment and a membrane C-terminal (50
CC       kDa) fragment. Proteolysis by MMP14 regulates PTK7 function in
CC       non-canonical Wnt signaling pathway.
CC       {ECO:0000269|PubMed:20837484}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Insulin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PTK7ID41901ch6p21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U33635; AAA87565.1; -; mRNA.
DR   EMBL; U40271; AAC50484.2; -; mRNA.
DR   EMBL; AF447176; AAL39062.1; -; Genomic_DNA.
DR   EMBL; AF447157; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447158; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447162; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447164; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447167; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447170; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447171; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447173; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447174; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF447175; AAL39062.1; JOINED; Genomic_DNA.
DR   EMBL; AF531868; AAN04862.1; -; mRNA.
DR   EMBL; AF531869; AAN04863.1; -; mRNA.
DR   EMBL; AF531870; AAN04864.1; -; mRNA.
DR   EMBL; AF531871; AAN04865.1; -; mRNA.
DR   EMBL; AF531872; AAN04866.1; -; mRNA.
DR   EMBL; AK291016; BAF83705.1; -; mRNA.
DR   EMBL; AK292589; BAF85278.1; -; mRNA.
DR   EMBL; AK296953; BAH12463.1; -; mRNA.
DR   EMBL; AL355385; CAI13783.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04154.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04155.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04156.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04158.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04160.1; -; Genomic_DNA.
DR   EMBL; BC071557; AAH71557.1; -; mRNA.
DR   CCDS; CCDS4884.1; -. [Q13308-1]
DR   CCDS; CCDS4885.1; -. [Q13308-2]
DR   CCDS; CCDS4886.1; -. [Q13308-3]
DR   CCDS; CCDS4887.1; -. [Q13308-4]
DR   CCDS; CCDS59021.1; -. [Q13308-6]
DR   PIR; JC4593; JC4593.
DR   RefSeq; NP_001257327.1; NM_001270398.1. [Q13308-6]
DR   RefSeq; NP_002812.2; NM_002821.4. [Q13308-1]
DR   RefSeq; NP_690619.1; NM_152880.3. [Q13308-2]
DR   RefSeq; NP_690620.1; NM_152881.3. [Q13308-3]
DR   RefSeq; NP_690621.1; NM_152882.3. [Q13308-4]
DR   UniGene; Hs.90572; -.
DR   ProteinModelPortal; Q13308; -.
DR   SMR; Q13308; -.
DR   BioGrid; 111721; 9.
DR   IntAct; Q13308; 14.
DR   MINT; MINT-4532536; -.
DR   STRING; 9606.ENSP00000230419; -.
DR   iPTMnet; Q13308; -.
DR   PhosphoSitePlus; Q13308; -.
DR   SwissPalm; Q13308; -.
DR   UniCarbKB; Q13308; -.
DR   BioMuta; PTK7; -.
DR   DMDM; 116242736; -.
DR   EPD; Q13308; -.
DR   MaxQB; Q13308; -.
DR   PaxDb; Q13308; -.
DR   PeptideAtlas; Q13308; -.
DR   PRIDE; Q13308; -.
DR   TopDownProteomics; Q13308-3; -. [Q13308-3]
DR   DNASU; 5754; -.
DR   Ensembl; ENST00000230418; ENSP00000230418; ENSG00000112655. [Q13308-5]
DR   Ensembl; ENST00000230419; ENSP00000230419; ENSG00000112655. [Q13308-1]
DR   Ensembl; ENST00000345201; ENSP00000325992; ENSG00000112655. [Q13308-2]
DR   Ensembl; ENST00000349241; ENSP00000325462; ENSG00000112655. [Q13308-3]
DR   Ensembl; ENST00000352931; ENSP00000326029; ENSG00000112655. [Q13308-4]
DR   Ensembl; ENST00000481273; ENSP00000418754; ENSG00000112655. [Q13308-6]
DR   GeneID; 5754; -.
DR   KEGG; hsa:5754; -.
DR   UCSC; uc003oub.3; human. [Q13308-1]
DR   CTD; 5754; -.
DR   DisGeNET; 5754; -.
DR   GeneCards; PTK7; -.
DR   HGNC; HGNC:9618; PTK7.
DR   HPA; HPA003222; -.
DR   MIM; 601890; gene.
DR   neXtProt; NX_Q13308; -.
DR   OpenTargets; ENSG00000112655; -.
DR   PharmGKB; PA33961; -.
DR   eggNOG; KOG1026; Eukaryota.
DR   eggNOG; KOG4475; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118818; -.
DR   HOGENOM; HOG000115767; -.
DR   HOVERGEN; HBG008320; -.
DR   InParanoid; Q13308; -.
DR   KO; K05127; -.
DR   OrthoDB; EOG091G0BWE; -.
DR   PhylomeDB; Q13308; -.
DR   TreeFam; TF326835; -.
DR   SIGNOR; Q13308; -.
DR   ChiTaRS; PTK7; human.
DR   GeneWiki; PTK7; -.
DR   GenomeRNAi; 5754; -.
DR   PRO; PR:Q13308; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112655; -.
DR   CleanEx; HS_PTK7; -.
DR   ExpressionAtlas; Q13308; baseline and differential.
DR   Genevisible; Q13308; HS.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:1904929; F:coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB.
DR   GO; GO:0003401; P:axis elongation; IEA:Ensembl.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0016477; P:cell migration; IMP:UniProtKB.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IMP:BHF-UCL.
DR   GO; GO:0090103; P:cochlea morphogenesis; IEA:Ensembl.
DR   GO; GO:0060026; P:convergent extension; IEA:Ensembl.
DR   GO; GO:0060976; P:coronary vasculature development; IEA:Ensembl.
DR   GO; GO:0045198; P:establishment of epithelial cell apical/basal polarity; IEA:Ensembl.
DR   GO; GO:0001736; P:establishment of planar polarity; IEA:Ensembl.
DR   GO; GO:0060484; P:lung-associated mesenchyme development; IEA:Ensembl.
DR   GO; GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IEA:Ensembl.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0003281; P:ventricular septum development; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 7.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR033592; PTK7.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   PANTHER; PTHR26391:SF20; PTHR26391:SF20; 1.
DR   Pfam; PF07679; I-set; 3.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00409; IG; 7.
DR   SMART; SM00408; IGc2; 7.
DR   SUPFAM; SSF48726; SSF48726; 7.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50835; IG_LIKE; 7.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell junction; Complete proteome;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Membrane;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix; Wnt signaling pathway.
FT   SIGNAL        1     30       {ECO:0000255}.
FT   CHAIN        31   1070       Inactive tyrosine-protein kinase 7.
FT                                /FTId=PRO_0000016748.
FT   TOPO_DOM     31    704       Extracellular. {ECO:0000255}.
FT   TRANSMEM    705    725       Helical. {ECO:0000255}.
FT   TOPO_DOM    726   1070       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       31    120       Ig-like C2-type 1.
FT   DOMAIN      128    218       Ig-like C2-type 2.
FT   DOMAIN      225    317       Ig-like C2-type 3.
FT   DOMAIN      309    407       Ig-like C2-type 4.
FT   DOMAIN      412    497       Ig-like C2-type 5.
FT   DOMAIN      503    586       Ig-like C2-type 6.
FT   DOMAIN      578    680       Ig-like C2-type 7.
FT   DOMAIN      796   1066       Protein kinase; inactive.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   REGION      794   1070       Interaction with CTNNB1.
FT                                {ECO:0000269|PubMed:21132015}.
FT   SITE        621    622       Cleavage; by MMP14.
FT   MOD_RES    1064   1064       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BKG3}.
FT   CARBOHYD    116    116       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    175    175       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    184    184       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    214    214       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    268    268       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    283    283       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    405    405       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    463    463       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    567    567       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    646    646       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:19159218}.
FT   DISULFID     53    101       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    150    200       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    246    301       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    343    391       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    433    481       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    524    570       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    613    664       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VAR_SEQ       1     26       MGAARGSPARPRRLPLLSVLLLPLLG -> MGSFLSGEKRP
FT                                SAPTVGSAMEKKEFPTPPGRVGP (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044775.
FT   VAR_SEQ     410    540       TVPSWLKKPQDSQLEEGKPGYLDCLTQATPKPTVVWYRNQM
FT                                LISEDSRFEVFKNGTLRINSVEVYDGTWYRCMSSTPAGSIE
FT                                AQARVQVLEKLKFTPPPQPQQCMEFDKEATVPCSATGREKP
FT                                TIKWERAD -> N (in isoform 3).
FT                                {ECO:0000303|PubMed:12427550}.
FT                                /FTId=VSP_037181.
FT   VAR_SEQ     500    539       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12427550,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_037182.
FT   VAR_SEQ     627    682       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:12427550}.
FT                                /FTId=VSP_037183.
FT   VAR_SEQ     804    816       KSEFGEVFLAKAQ -> RPQAVPEDFQEQG (in
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:12427550}.
FT                                /FTId=VSP_037184.
FT   VAR_SEQ     817   1070       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:12427550}.
FT                                /FTId=VSP_037185.
FT   VARIANT     276    276       R -> H (in dbSNP:rs56188167).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041502.
FT   VARIANT     410    410       T -> S (in dbSNP:rs34021075).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041503.
FT   VARIANT     745    745       E -> D (in dbSNP:rs9472017).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041504.
FT   VARIANT     766    766       E -> Q (in dbSNP:rs56216742).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041505.
FT   VARIANT     777    777       A -> V (in dbSNP:rs34764696).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041506.
FT   VARIANT     783    783       H -> R (in dbSNP:rs55820547).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041507.
FT   VARIANT     933    933       A -> V (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041508.
FT   VARIANT    1029   1029       P -> T (in dbSNP:rs55755163).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041509.
FT   VARIANT    1038   1038       R -> Q (in dbSNP:rs34865794).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041510.
FT   MUTAGEN     622    622       L->D: Prevents proteolysis by MMP14.
FT                                {ECO:0000269|PubMed:20837484}.
FT   MUTAGEN     641    641       M->R: No impact on proteolysis by MMP14.
FT                                {ECO:0000269|PubMed:20837484}.
FT   MUTAGEN     701    701       M->D: No impact on proteolysis by MMP14.
FT                                {ECO:0000269|PubMed:20837484}.
FT   CONFLICT     87     87       F -> L (in Ref. 4; BAF85278).
FT                                {ECO:0000305}.
FT   CONFLICT     92     92       R -> P (in Ref. 1; AAA87565).
FT                                {ECO:0000305}.
FT   CONFLICT     93     93       L -> P (in Ref. 7; AAH71557).
FT                                {ECO:0000305}.
FT   CONFLICT    147    147       T -> K (in Ref. 1; AAA87565).
FT                                {ECO:0000305}.
FT   CONFLICT    207    207       G -> S (in Ref. 1; AAA87565).
FT                                {ECO:0000305}.
FT   CONFLICT    495    496       RV -> VL (in Ref. 1; AAA87565).
FT                                {ECO:0000305}.
FT   CONFLICT    515    515       E -> G (in Ref. 1; AAA87565).
FT                                {ECO:0000305}.
FT   CONFLICT    755    755       Q -> R (in Ref. 4; BAH12463).
FT                                {ECO:0000305}.
FT   CONFLICT    799    799       I -> F (in Ref. 4; BAF85278).
FT                                {ECO:0000305}.
FT   CONFLICT    881    881       G -> E (in Ref. 1; AAA87565).
FT                                {ECO:0000305}.
FT   CONFLICT    969    969       P -> A (in Ref. 1; AAA87565).
FT                                {ECO:0000305}.
FT   CONFLICT    992    992       F -> S (in Ref. 1; AAA87565).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1070 AA;  118392 MW;  304926A1774EB5F4 CRC64;
     MGAARGSPAR PRRLPLLSVL LLPLLGGTQT AIVFIKQPSS QDALQGRRAL LRCEVEAPGP
     VHVYWLLDGA PVQDTERRFA QGSSLSFAAV DRLQDSGTFQ CVARDDVTGE EARSANASFN
     IKWIEAGPVV LKHPASEAEI QPQTQVTLRC HIDGHPRPTY QWFRDGTPLS DGQSNHTVSS
     KERNLTLRPA GPEHSGLYSC CAHSAFGQAC SSQNFTLSIA DESFARVVLA PQDVVVARYE
     EAMFHCQFSA QPPPSLQWLF EDETPITNRS RPPHLRRATV FANGSLLLTQ VRPRNAGIYR
     CIGQGQRGPP IILEATLHLA EIEDMPLFEP RVFTAGSEER VTCLPPKGLP EPSVWWEHAG
     VRLPTHGRVY QKGHELVLAN IAESDAGVYT CHAANLAGQR RQDVNITVAT VPSWLKKPQD
     SQLEEGKPGY LDCLTQATPK PTVVWYRNQM LISEDSRFEV FKNGTLRINS VEVYDGTWYR
     CMSSTPAGSI EAQARVQVLE KLKFTPPPQP QQCMEFDKEA TVPCSATGRE KPTIKWERAD
     GSSLPEWVTD NAGTLHFARV TRDDAGNYTC IASNGPQGQI RAHVQLTVAV FITFKVEPER
     TTVYQGHTAL LQCEAQGDPK PLIQWKGKDR ILDPTKLGPR MHIFQNGSLV IHDVAPEDSG
     RYTCIAGNSC NIKHTEAPLY VVDKPVPEES EGPGSPPPYK MIQTIGLSVG AAVAYIIAVL
     GLMFYCKKRC KAKRLQKQPE GEEPEMECLN GGPLQNGQPS AEIQEEVALT SLGSGPAATN
     KRHSTSDKMH FPRSSLQPIT TLGKSEFGEV FLAKAQGLEE GVAETLVLVK SLQSKDEQQQ
     LDFRRELEMF GKLNHANVVR LLGLCREAEP HYMVLEYVDL GDLKQFLRIS KSKDEKLKSQ
     PLSTKQKVAL CTQVALGMEH LSNNRFVHKD LAARNCLVSA QRQVKVSALG LSKDVYNSEY
     YHFRQAWVPL RWMSPEAILE GDFSTKSDVW AFGVLMWEVF THGEMPHGGQ ADDEVLADLQ
     AGKARLPQPE GCPSKLYRLM QRCWALSPKD RPSFSEIASA LGDSTVDSKP
//
